The Center for Technology Licensing (CTL) is Cornell University's technology transfer office. We manage technology for Cornell's Ithaca campus, Weill Cornell Medicine, Cornell Tech, and Cornell AgriTech in Geneva.

Live Panel Discussion on Women Inventors at Cornell University

June 11, 2020

Join Center for Technology Licensing at Cornell University (CTL) for a live Panel Discussion on Women Inventors at Cornell University!


When: June 25, 2020 from 12 pm to 1 pm.


Alice Li, the Executive Director at CTL will be moderating a panel of women leaders from different industries and representing different stages of the commercialization process.


During the webinar, they will discuss approaches that we (Cornell Community) could take to overcoming gender disparity and inspire the future women innovators and entrepreneurial leaders.


In this panel we are excited to welcome:

Pamela Marrone, ’78, PhD, CEO/Founder, Marrone Bio Innovations, Inc. (MBI)


Dr. Marrone spent her career focused on natural products for pest management and for the last 30 years in Davis CA, where she started and led three companies dedicated to biological solutions for agriculture. She started Marrone Bio Innovations in 2006 to discover and develop bio-based products for pest management and plant health. On August 2, 2013, MBI listed its stock as MBII on NASDAQ. Before Marrone Bio, she started and led AgraQuest.


Before AgraQuest, she was founding president and business unit head for Entotech, Inc. She started her career after graduate school at Monsanto, where she led the Insect Biology group. She just completed her 4 year term as an alumni-elected Trustee of Cornell University. She is Treasurer of the Association for Women in Science, board member of the Foundation for Food and Ag Research, and is on the UC Davis Ag and Environmental Sciences Dean’s Advisory Council.


She mentors and advises a number of ag bio and agtech startups. She holds more than 60 US and 400 foreign patents and is a Fellow of AAAS. She has a B.S. in entomology with Honors and Distinction from Cornell and a Ph.D. in entomology from NCSU.


Anaïs Rameau, ’04, M.D., M.Phil., CEO, MyophonX and Assistant Professor of Otolaryngology, Weill Cornell Medical College.


Anaïs Rameau is assistant professor of otolaryngology – head and neck surgery at the Sean Parker Institute for the Voice, at Weill Cornell Medicine. Prior to joining Cornell, Dr. Rameau trained at Stanford University where she established the groundwork of her current clinical practice and research. As a clinician, she provides medical and surgical care to patients with voice, swallowing and airway problems. As a researcher, she focuses on the development of novel technologies to benefit older persons at risk of pneumonia and to restore voice in individuals who have lost their larynx to cancer. Her work is currently supported by federal, institutional and foundational grants.


Since her early education at the Lycée Lakanal, Dr. Rameau has valued arts and science education. She founded Logos, the first undergraduate journal of philosophy at Cornell University, now in its 15th year of publication, and after medical school, she pursued an MPhil History and Philosophy of Science at Cambridge University to study the epistemological basis of medical knowledge. She lectures on the nature of surgical knowledge and bioethical issues specific to surgery. She is a mentor to undergraduate, graduate, medical and postdoctoral students in both the sciences and the humanities.


Anaïs Rameau is co-founder of MyophonX, a startup that has created an individually tailored wearable device that applies machine learning to silent articulation to restore speech in patients with limited phonation or ability to speak. MyophonX won the 2018 Weill Cornell Hackathon, and was selected to the 2019 Entrepreneurship Lab cohort, a competitive accelerator program launched by the City of New York. Anaïs pitched MyophonX at the 2019 Cornell Entrepreneurship Summit in the Times building. She currently has one filed patent via Cornell CTL and is working on a second provisional patent submission.


Ponsi Trivisvavet, MBA ’99, CEO & Director, Inari Ag.


Ponsi Trivisvavet is CEO and Director of Inari, a seed company using breakthroughs in genomic and computational science to transform plant breeding and radically reduce the amount of natural resources needed to grow our food. Ms. Trivisvavet has broad expertise in global agriculture as well as extensive management skill in the seeds business.


Prior to joining Inari, she held a number of leadership roles at Syngenta, most recently as president of Syngenta Seeds North America. Before Syngenta, she held positions with McKinsey & Company. Ms. Trivisvavet holds an MBA from Cornell University.


Beth Xie, MBA ’10, Startup Advisor and Investor & Former CEO and Co-Founder, Taggpic, Inc.


MBA ’10, Startup Advisor and Investor& Former CEO and Co-Founder, Taggpic, Inc.
As an entrepreneur, Beth was the CEO and Co-founder of TaggPic, an NSF SBIR winning computer vision startup that delivered location and image content recognition to real-world exploration and navigation. Beth led TaggPic from inception to its acquisition by Google.


As an advisor, Beth mentors and invests in deep tech startups focused on using machine learning, artificial intelligence and other innovative tools to disrupt various markets and ecosystems. Beth is currently a NYC Regional Innovation Node I-Corps adjunct faculty. She also served as an industry mentor for the NSF National Level I-Corps Winter 2020 cohort. She earned her MBA from Cornell University and a bachelor’s degree in computer science from the University of Arizona.


Moderated by

Alice Li, Ph.D. ’98, CLP, Executive Director of the Center for Technology Licensing (CTL) at Cornell University


Registration Link:


Contact information:
Lynda Inseque, Program Manager, Technology Initiatives & Outreach,